Connect Sign In
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on complement deficiency testing, hereditary cancer assessment, and rapid whole genome sequencing.
In closing remarks at a Rare Disease Day event, ARUP CEO Andy Theurer thanked young people sharing their stories for inspiring the laboratory scientists who are working to improve diagnosis.
The addition of GAMT deficiency to the federal Recommended Uniform Screening Panel is an important milestone for ARUP medical directors and a Utah mom who say the change will improve lives.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on testing for bariatric surgery, respiratory viruses, and alpha-1-antitrypsin deficiency.
A $3.6 million gift from the Miller family will enable University of Utah Health and ARUP to expand and refine testing for rare genetic disorders through the Utah NeoSeq Project.
In September, ARUP Consult, a free informative resource in laboratory testing, released new user experience (UX) upgrades and updated several topics, including acute lymphoblastic leukemia.
Assistant Professor (Clinical), University of Utah School of Medicine Specialties Hematopathology Molecular genetic pathology Education Medical Degree—Bogomolets National Medical University Doctorate Degree—University of Utah Residency—Anatomical and Clinical Pathology, University of…
New research published in Blood sheds light on diagnosis, disease characteristics, and prognoses for inherited hematologic malignancies associated with DDX41 germline variants.
Professor, University of Utah School of MedicineSpecialtiesHematopathologyMolecular pathologyTranslational researchInnovationEducationMedical Degree—Harvard Medical SchoolDoctorate Degree—Harvard UniversityResidency—Anatomic Pathology, Stanford UniversityFellowship—Hematopathology, Stanford…
ARUP Consult, a free source of expert guidance in laboratory testing, offers valuable information on relevant topics from monkeypox to HLA testing and more.
